Health Company Now Provides Two Product Variations After Receiving Feedback on a New Formula
Meridian, Idaho, September 21, 2021 — Due to popular demand, CellCore Biosciences' product MitoATP will now be available in two different formula variations. The original formula will be available once again as MitoATP, while the latest formula released in May will be provided as MitoDTX.
The latest formula was designed to provide deeper detoxification; however, there were reports that it caused increased detox symptoms for certain customers. To provide the maximum opportunity for customization to meet the needs of patients, CellCore will now provide practitioners two formula options.
Dr. Todd Watts, CEO and co-founder of CellCore, says, “We are glad to be able to provide MitoATP’s original formula to continue to give patients a natural energy boost and support cells at the mitochondrial level, while MitoDTX will offer deeper detoxification for those further along their health journeys.”
He continues, “We trust our practitioners to gauge the need and tolerance for these products to assist patients in the best way possible.”
The timeline for the release of the newly labeled MitoDTX is to be determined.
The original formula of MitoATP will be distributed again for all orders placed after September 20, 2021. You can learn more about MitoATP and other products on the CellCore website.
About CellCore Biosciences: CellCore Biosciences is a wellness company that believes a “healthy microbiome is a healthy you.” This starts with opening drainage pathways, supporting energy at the mitochondrial level, and detoxing unwanted substances. Their core values are front and center in the company mission: “Creating solutions that work is what we do. Restoring hope and health is who we are.”
If you would like more information about this topic, please contact Jessica Tidwell, Public Relations Manager for CellCore Biosciences, at email@example.com.